Gcn5 and Esa1 function as histone crotonyltransferases to regulate crotonylation-dependent transcription by Kollenstart, Leonie et al.
Gcn5 and Esa1 function as histone crotonyltransferases to
regulate crotonylation-dependent transcription
Received for publication, July 23, 2019, and in revised form, October 10, 2019 Published, Papers in Press, November 7, 2019, DOI 10.1074/jbc.RA119.010302
Leonie Kollenstart‡, Anton J. L. de Groot‡, X George M. C. Janssen§, Xue Cheng¶, Kees Vreeken‡, Fabrizio Martino,
X Jacques Côté¶, Peter A. van Veelen§, and X Haico van Attikum‡1
From the ‡Department of Human Genetics, Leiden University Medical Center, Einthovenweg 20, 2333 ZC, Leiden, The Netherlands,
the §Center for Proteomics and Metabolomics, Leiden University Medical Center, Albinusdreef 2, 2333 ZC, Leiden, The Netherlands,
the ¶St. Patrick Research Group in Basic Oncology, Laval University Cancer Research Center, Centre de Recherche du Centre
Hospitalier Universitaire de Québec-Axe Oncologie, Québec City, QC G1R 3S3, Canada, and the Centro de Investigaciones
Biológicas (CIB), Consejo Superior de Investigaciones Científicas (Spanish National Research Council) , (CSIC), Ramiro de Maeztu 9,
28040 Madrid, Spain
Edited by John M. Denu
Histone post-translational modifications (PTMs) are critical for
processes such as transcription. The more notable among these are
the nonacetyl histone lysine acylation modifications such as croto-
nylation, butyrylation, and succinylation. However, the biological
relevance of these PTMs is not fully understood because their reg-
ulation is largely unknown. Here, we set out to investigate whether
the main histone acetyltransferases in budding yeast, Gcn5 and
Esa1, possess crotonyltransferase activity. In vitro studies revealed
that the Gcn5-Ada2-Ada3 (ADA) and Esa1-Yng2-Epl1 (Piccolo
NuA4) histone acetyltransferase complexes have the capacity to
crotonylate histones. Mass spectrometry analysis revealed that
ADA and Piccolo NuA4 crotonylate lysines in the N-terminal tails
of histone H3 and H4, respectively. Functionally, we show that cro-
tonylation selectively affects gene transcription in vivo in a man-
ner dependent on Gcn5 and Esa1. Thus, we identify the Gcn5-
and Esa1-containing ADA and Piccolo NuA4 complexes as
bona fide crotonyltransferases that promote crotonylation-
dependent transcription.
Post-translational modifications (PTMs)2 on histones pro-
vide chromatin with a layer of regulation for vital processes
such as gene transcription, DNA replication, and DNA damage
repair (1–3). The maintenance of PTMs through modifying
enzymes called “writer” and “eraser” proteins, which add and
remove PTMs, respectively, is critical for these processes. The
identification and characterization of writers and erasers has
brought insight into the functional relevance of many PTMs,
most notably that of histone acetylation, in gene transcription
(4, 5). Through various MS-based approaches, the repertoire of
PTMs has been expanding rapidly. The more notable among
these are the nonacetyl histone lysine acylation modifications
such as crotonylation, butyrylation, and succinylation (6 –10).
Histone acylation marks, similar to those induced through
acetylation, are linked to active gene transcription (7, 11, 12). In
recent years, the first writers and erasers have been identified
for various acylation marks. The well-characterized histone
acetyltransferase (HAT) p300 and KAT2A (hGCN5) possess
crotonyltransferase and succinyltransferase activity, respec-
tively, toward histones (11, 13), whereas class I histone deacety-
lases (HDACs) (HDAC1, HDAC2, HDAC3, and HDAC8) and
class III HDACs (SIRT1, SIRT2 and SIRT3) are capable of
decrotonylating histones (14 –16). However, compared with
histone acetylation, the regulation of crotonylation, butyryla-
tion, and succinylation is still poorly understood. This may
be in part due to specificity issues of some antibodies, par-
ticularly those against histone crotonylation and butyryla-
tion (17, 18).
For histone acetylation, the identification and characteriza-
tion of HATs and HDACs as writers and erasers was vital for
understanding its function. Because some HATs also possess
acyltransferase activity (11, 19, 20), we set out to investigate
whether the main HATs in yeast, Gcn5 and Esa1, are writers of
histone crotonylation in budding yeast. Gcn5 and Esa1 have
previously been implicated in histone crotonylation by genetic
experiments (20, 21), although neither human GCN5 nor Esa1
and its human homologue MOF exhibited any crotonyltransferase
activity in vitro (11, 20, 21). Here, we reveal both the in vitro and in
vivo activities of the Gcn5-Ada2-Ada3 (ADA) and Esa1-Yng2-
Epl1 (Piccolo NuA4) complexes, thereby identifying these com-
plexes as writers of histone H3 and H4 crotonylation, respec-
tively. Moreover, we show that crotonate treatment triggers
a transcription response that depends on Gcn5- and Esa1-
dependent histone crotonylation. Thus, the ADA and Pic-
colo NuA4 complexes exhibit crotonyltransferase activity
toward chromatin and are regulators of crotonylation-de-
pendent transcription.
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Gcn5 is a novel histone crotonyltransferase in vitro
Because a role for Gcn5 and Esa1 in crotonylation had not
been properly described, we examined whether Gcn5 and
Esa1 are bona fide writers of this modification in budding
yeast. To this end, we first purified Gcn5 from Escherichia
coli (Fig. S1A), and tested whether it can directly crotonylate
chromatin in vitro using a histone acylation transferase
assay. Acetyl-CoA (positive control) and crotonyl-CoA were
used as acyl-donors in this assay. The outcome of the reac-
tions was analyzed by Western blot analysis using different
pan-K-acyl-specific antibodies. Gcn5 alone, in contrast to
the core ADA complex consisting of Gcn5, Ada2, and Ada3,
displays weak acetylation activity toward nucleosomes (22,
23), which we confirmed in our assays (Fig. S2A). In addition,
we also did not observe crotonylation activity (Fig. S2B). We
therefore purified the core ADA (Gcn5, Ada2, and Ada2)
complex from E. coli (Fig. S1, B and C) and tested its activity
on histone octamers and on in vitro reconstituted mono-
nucleosomes (Fig. S1D) (24). As previously shown, the core
ADA complex displayed robust acetylation activity mainly
toward histone H3 in both histone octamers and nucleo-
somes (Fig. 1A, Fig. S3A). This activity depended on the cat-
alytic glutamic acid residue on position 173 in Gcn5, because
changing it to histidine (Gcn5-E173H) abrogated acetyla-
tion, agreeing with previous reports (Fig. 1A) (22, 25).
Importantly, the ADA complex also exhibited crotonyltrans-
ferase activity toward histone octamers and nucleosomes in
a manner dependent on its catalytic activity (Fig. 1, A and B,
and Fig. S3B). Thus, we identified the ADA complex as a
writer of histone crotonylation in vitro.
Gcn5 targets specific lysines in histone H3 for crotonylation
We then sought to confirm the presence of crotonyl mod-
ifications on histone H3 and investigate which lysines in his-
tone H3 are targeted for crotonylation by Gcn5. We there-
fore performed in vitro crotonyltransferase assays using
mononucleosomes, separated the reaction products on SDS-
PAGE and stained the gel by Coomassie. Bands correspond-
ing to H3 were cut out and samples were analyzed by MS.
This revealed that Gcn5 acetylates lysine residues at posi-
tions 9, 14, 18, 23, and 27 in histone H3 (Fig. 1, C–E, and Fig.
Figure 1. The ADA complex crotonylates histone H3 in mononucleosomes in vitro. Western blot analysis of in vitro (A) histone acetyltransferase, (B) histone
crotonyltransferase reactions with recombinant WT and catalytically-dead (Gcn5-E173H) ADA complex and mononucleosomes as a substrate. C and D, MS2
spectra of peptides corresponding to a region spanning Lys-9 –Arg-17 in histone H3 showing (C) unmodified (but deutero-acetylated) K9 and K14 (green), (D)
crotonylated K14 (red) with deuterated acetic acid (d) acetylations in green. E, schematic depicting residues 1–37 of H3 with acetylated (ac, green) and
crotonylated (cr, red) lysine residues as identified by MS.
Gcn5 and Esa1 function as histone crotonyltransferases
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S4). Likewise, Gcn5 targeted the same residues for crotony-
lation (Fig. 1E), all of which were known to be acetylated (25).
These results were confirmed by Western blot analysis of the
in vitro reaction products using site-specific antibodies for
H3 lysine 9, 14, and 18 (Fig. S5). Of note, two bands were
detected, likely representing differently modified H3 species
(Fig. S5). We validated these antibodies by Western blot
analysis using extracts from yeast cells expressing H3K9A,
K3K14A, and H3K18A substitutions. The signal observed in
the WT strain was lost in the substitution mutants (Fig. S6,
A–C), whereas expression of histone H3 was not affected in
any of these mutants (Fig. S6D) indicating site-specificity of
these antibodies. Thus, the ADA complex is capable of
directly modifying chromatin by acetylation, as well as cro-
tonylation, targeting the same residues in histone H3.
Esa1 is a novel histone crotonyltransferase in vitro
Esa1, similar to Gcn5, is unable to acetylate chromatin sub-
strates in the absence of its members in the NuA4 complex (26,
27). In addition, Esa1 alone does not possess any crotonyltrans-
ferase activity (20). We therefore purified Esa1 in the presence
of Epl1 and Yng2, which are the two other subunits of the Esa1-
containing Piccolo NuA4 histone acetyltransferase complex
(27) from E. coli (Fig. S7, A and B) (28), and tested its activity
toward mononucleosomes in vitro. As expected, the Piccolo
NuA4 complex displayed robust acetylation activity mainly
toward histone H4 (Fig. 2A) (23). This activity depended on the
catalytic glutamic acid residue on position 338 in Esa1, because
changing it to glutamine (Esa1-E338Q) abrogated acetylation,
agreeing with previous reports (Fig. 2A) (29, 30). The Piccolo
NuA4 complex, similar to the ADA complex, also exhibited cro-
tonyltransferase activity toward nucleosomes in a manner depen-
dent on its catalytic activity (Fig. 2B). Thus, we identified the Pic-
colo NuA4 complex as a writer of histone crotonylation in vitro.
Esa1 targets specific lysines in histone H4 for crotonylation
To ascertain the presence of crotonyl modifications on
histone H4 and identify the lysines in histone H4 that are
crotonylated by Esa1, we examined reaction products from
the acyltransferase assay by MS. Similar to the approach for
Gcn5, we cut out H4 bands from SDS-PAGE gels and exam-
ined the samples by MS. This revealed that Esa1 acetylates
lysine residues at positions 5, 8, 12, and 16 in histone H4 for
acetylation (Fig. S8), which is in agreement with previous
Figure 2. The Piccolo NuA4 complex crotonylates histone H4 in mononucleosomes in vitro. Western blot analysis of in vitro (A) histone acetyltransferase,
(B) histone crotonyltransferase reactions with recombinant WT and catalytically-dead (Esa1-E338Q) Piccolo complex and mono- nucleosomes as a substrate.
C and D, mass spectrometry spectra of peptides corresponding to a region spanning Gly-4 –Arg-17 in histone H4 showing (C) unmodified (but deutero-
acetylated) K5, K8, K12, and K16 (green), (D) crotonylated K5 (red) with deuterated (d) acetylations in green. E, schematic depicting residues 1–37 of H4 with
acetylated (ac, green) and crotonylated (cr, red) lysine residues as identified by MS.
Gcn5 and Esa1 function as histone crotonyltransferases
20124 J. Biol. Chem. (2019) 294(52) 20122–20134









reports (26, 27). Importantly, Esa1 also targeted the same
residues for crotonylation (Fig. 2, D and E, Fig. S8). There-
fore, the Piccolo NuA4 complex is capable of directly modi-
fying chromatin by acetylation, as well as crotonylation, tar-
geting the same residues in histone H4.
Metabolic regulation of crotonylation is Gcn5- and
Esa1-dependent
Following our in vitro studies on the role of Gcn5 and Esa1 in
crotonylation, we sought to address the relevance of these
Gcn5-dependent and Esa1-dependent modifications in vivo.
To this end, we added external sodium crotonate to the yeast
medium. This compound can be ligated into the corresponding
acyl-CoAs, as previously shown in human cells (11). Indeed,
crotonate addition increased crotonylation on histone H3 (Fig.
3A) and this was largely dependent on the presence of the yeast
acetyl-CoA synthetase enzymes Acs1 and Acs2 (Fig. 3A). To
further study these crotonate-induced changes, we performed
Western blot analysis of H3K9cr H3K14cr and H3K18cr in
yeast chromatin following crotonate treatment (Fig. S6).
Importantly, whereas the signals for these marks moderately
increased following crotonate treatment of WT cells, the
H3K9cr, H3K14cr and H3K18cr signals were lost in yeast cells
expressing the H3K9A, H3K14A and H3K18A substitutions
(Fig. S6). This finding suggests site-specific crotonyl recogni-
tion of these antibodies under increased crotonate conditions.
To corroborate these findings, we also examined crotonylation
in chromatin from WT yeast cells by MS. As a control, we
included chromatin from HeLa cells, in which the relative
abundances of H3K14ac and H3K14cr was around 8 and 0.02%,
respectively (31). In WT yeast that were treated with crotonate
or left untreated, we did not detect crotonylation on the histone
tails of H4, indicative of low abundance of this modification. In
accordance with these findings, crotonylation could also not be
detected on the histone tails of H4 from HeLa cells (17). How-
ever, we identified crotonylation on the N-terminal tail of H3 in
chromatin from crotonate-treated WT yeast cells. Specifically,
we found lysine 9, 14, and 23 to be crotonylated (Fig. 3, B–F).
These lysines were among the residues targeted by Gcn5 cro-
tonylation in vitro (Fig. 1, Fig. S4), indicating a Gcn5-dependent
crotonate response that involves H3 crotonylation in vivo.
To examine whether Gcn5 and Esa1 are responsible for cro-
tonylation in vivo, we examined crotonate-induced crotonyla-
tion in the absence of these enzymes. We observed a dose-de-
pendent increase in histone crotonylation, which was reduced
in the absence of Gcn5 (Fig. 3G, Fig. S9). Because Esa1 is an
essential gene, we employed the anchor-away technique to rap-
idly deplete FRB-tagged Esa1 from the nucleus following rapa-
mycin treatment (32). As expected, rapamycin treatment
severely reduced histone acetylation, although levels in the
nontagged/no-FRB strain remained unaffected (Fig. S10).
Importantly, crotonate-induced histone crotonylation was also
reduced in the rapamycin-treated Esa1-N-FRB strain (Fig. 3I,
Fig. S9). We did not observe cross-talk between crotonylation
and acetylation because crotonylation was not affected by the
addition of acetate (Fig. 3, G and I), which is known to affect
acetylation (33). Likewise, adding crotonate to the medium did
not lead to a change in the acetylation levels (Fig. 3, H and J).
Similarly, changes in the abundance of succinyl-CoA did not
affect acetylation levels (19). We therefore conclude that his-
tone crotonylation responds to metabolic changes in crotonyl-
CoA abundance in a manner dependent on Gcn5 and Esa1.
Gcn5 and Esa1 mediate crotonylation-dependent
transcription
To investigate the relevance of metabolic regulation of crotony-
lation, we decided to study its effect on transcription. WT cells
were grown in the absence or presence of crotonate for 3.5 h and
mRNA was isolated and deep-sequenced (Fig. 4A). We identified
880 transcripts that were differentially expressed following cro-
tonate treatment (p  0.05). In contrast to a previous report sug-
gesting that crotonylation has a stimulatory effect on transcription
(11, 34), we found that transcript levels were both increased and
decreased (Table S1, Fig. 4B). This may suggest that crotonylation
can both promote and suppress transcription. A GO term analysis
of the differentially expressed genes (1.5-fold change) revealed
that crotonate mainly influenced the expression of genes involved
in glucose (p  0.000016) and pentose transport (p  0.000027)
(Fig. 4B, Table S1), several of which (e.g. HXT1, HXT2, HXT4,
HXT7, HXK1, and RGT2) respond similarly to high glucose levels
(35) (Table S1). Importantly, for a selection of genes we could con-
firm the observed transcriptional changes by using reverse tran-
scription (RT)-qPCR (Fig. 5). Because we found that crotonate-
induced crotonylation relies on Gcn5 and Esa1 (Fig. 5), we next
asked if the crotonate-induced transcriptional changes also
depend on Gcn5 and Esa1. Indeed, RT-qPCR showed that the up-
and down-regulation of the selected genes was determined by
either Gcn5 and/or Esa1 (Fig. 5). To exclude indirect effects of
crotonate treatment on gene expression, we investigated if the cro-
tonate-induced transcriptional changes also appear at an earlier
time point (Fig. 5). Indeed, transcriptional changes already
appeared after 2 h of crotonate treatment and were also dependent
on Gcn5 and Esa1. This demonstrates that the metabolic state of
cells controls gene transcription in a manner dependent on Gcn5’s
and Esa1’s crotonyltransferase activity.
Gcn5 and Esa1 are recruited to a subset of crotonate-induced
genes
To investigate the direct effect of the ADA and Piccolo NuA4
complexes on crotonate-induced transcriptional changes, we
studied their occupancy at promoters of genes that are regu-
lated by crotonate. Although both Gcn5 (ADA complex) and
Epl1 (Piccolo NuA4 complex) were not recruited to the down-
regulated genes ADE17, SHM2, and HXT1 at 2 and 3.5 h after
crotonate treatment, we observed recruitment to a subset of the
up-regulated genes upon stimulation with crotonate (Fig. 6, A
and C). In addition, the SAGA subunit Spt7 was also recruited
to both BTN2 and ROX1 upon crotonate stimulation (Fig. 6B),
suggesting that Gcn5 regulates crotonate-induced transcrip-
tional as the catalytic subunit of both the ADA and SAGA com-
plexes. To rule out that the transcriptional changes were
induced by Gcn5- and Esa1-dependent acetylation, we moni-
tored the acetylation status of several gene promoters following
crotonate stimulation. Importantly, no major crotonate-in-
duced changes in the acetylation levels were observed at these
promoters (Fig. S11). Taken together, these results suggest that
Gcn5 and Esa1 function as histone crotonyltransferases
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the ADA/SAGA and Piccolo NuA4 complexes are able to
directly regulate crotonate-induced transcription indepen-
dently of histone acetylation.
Discussion
Here, we found that the ADA and Piccolo NuA4 complexes
exhibit crotonylation activities in vitro, revealing these com-
plexes as bona fide acylation writers. Previously, it was reported
that neither KAT2A (hGCN5) nor its homologue P300/CBP-
associated factor (PCAF) possesses crotonylation activity in
vitro (11). Although Gcn5 and KAT2A may display the same
functionality, the lack of ADA subunits in the in vitro assays
could explain the lack of activity. Indeed, both Gcn5 and
KAT2A were shown to display reduced acetyltransferase activ-
ity in the absence of Ada2 and Ada3 (22, 36). Similarly, Esa1
requires the presence of its NuA4 complex members, Yng2 and
Epl1, to crotonylate (Fig. 2B). In addition, the activity of various
HATs toward longer acyl-CoA chains, such as crotonyl-CoA or
succinyl-CoA, was found to be decreased (17, 37, 38). Similarly,
Gcn5 and Esa1 may also function as weak crotonyltransferases,
even in the context of the ADA and Piccolo NuA4 complexes.
Such scenarios would be in accordance with the limited detec-
tion of histone crotonylation by MS and the generally lower
abundance of nonacetyl acylations compared with acetylation
(17). Although loss of Gcn5 or Esa1 substantially decreased cro-
tonylation levels, in their absence, crotonate-induced crotony-
lation was not fully inhibited (Fig. 3, G–I, Fig. S9). Therefore,
other enzymes may partly compensate Gcn5 or Esa1 crotonyl-
transferase activities.
Because both Gcn5 and Esa1 recognize various acyl-CoAs
and function as broad acyltransferases, it is challenging to
distinguish the effects of specific acylation modifications on
cellular processes. For p300 and KAT2A, which also recognize
multiple acyl-CoAs, separation-of-function mutants were con-
structed to eliminate broad substrate specificity and generate
substrate-specific acyltransferases (19, 20). An acetylation-de-
ficient, but crotonylation-proficient p300 mutant remained
competent in promoting transforming growth factor-1–
induced gene activation, attributing a role for crotonylation in
transcriptional regulation (20). Expression of a succinylation-
deficient, but acetylation-proficient KAT2A mutant inhibited
tumor growth in mice, demonstrating that succinylation has
nonredundant roles to acetylation (19). By analogy, identifying
separation-of-function mutants for Gcn5 or Esa1, which are
defective in crotonylation yet proficient in generating other
acylation modifications, would enable genetic studies on Gcn5-
or Esa1-induced crotonylation and its contribution to cellular
processes.
Here we modulated crotonylation at the metabolic level by
exposing cells to crotonate. The subsequent increase in histone
crotonylation invoked various transcriptional changes, partic-
ularly in metabolic pathways related to glucose transport, in a
manner dependent on Gcn5 and/or Esa1. Considering in-
creased crotonylation mimics certain transcriptional changes
seen under high glucose levels, crotonyl-CoA levels could be
influenced by glucose availability, as described for acetyl-CoA
(33). Similarly, high glucose increases Gcn5-dependent acety-
lation and enhances recruitment of Gcn5 to promoters of genes
involved in growth regulation (39 –41). We infer that Gcn5 and
Esa1 may couple the metabolic state of cells to transcriptional
changes through various histone acylation modifications, in
line with previous reports that link the availability of acyl-CoA
metabolites to their corresponding histone acylation levels (17).
Several genes were regulated by crotonate treatment of cells.
To assess whether these genes were regulated by promoter cro-
tonylation, we examined the recruitment of several subunits of
the crotonyl writer complexes ADA/SAGA (Gcn5 and Spt7)
and Piccolo NuA4 (Epl1) as a proxy for crotonylation at these
promoters. Indeed, these complexes were recruited to promot-
Figure 3. Crotonate affects histone crotonylation in Gcn5- and Esa1-dependent manner. A, WT, acs1 and acs2_DAmP strains were treated with sodium
crotonate (10 mM, pH 7.5) for 3.5 h in the presence of 0.8 M sorbitol. Whole cell extracts were immunoblotted with the indicated antibodies. B–F, MS2 spectra
of peptides corresponding to a region spanning Lys-9 –Arg-17 in histone H3 showing (B) unmodified (but deuteroacetylated) K9 and K14 (green), (C) crotony-
lated K9 (red), and (D) crotonylated K14 (red). E and F, MS2 spectra of peptides corresponding to a region spanning Lys-18 –Arg-21 in histone H3 showing (E)
unmodified (but deuteroacetylated) K18 and K23 (green) and (F) crotonylated K23 (red). G and H, WT and gcn5 strains were treated with (G) increasing
concentrations of sodium crotonate (1, 2, 5, and 10 mM, pH 7.5) or sodium acetate (10 mM, pH 7.5) or (H) sodium crotonate (10 mM, pH 7.5) for 3.5 h in the
presence of 0.8 M sorbitol. Whole cell extracts were immunoblotted with the indicated antibodies. I and J, nontagged (no FRB) and Esa1-N-FRB tagged strains
were treated as in G and H in the presence of rapamycin. Whole cell extracts were immunoblotted with the indicated antibodies.
Figure 4. Crotonate induces various transcription changes. A, schematic
of RNA-Seq analysis performed in triplicate on WT yeast strains treated with
10 mM crotonate for 3.5 h. B, volcano plot depicting crotonate-induced tran-
scriptome changes. Genes showing a 1.5-fold change in expression (n 
106) are highlighted in red, genes tested for follow-up are identified in the
plot. C, GO term analysis of significantly changed genes.
Gcn5 and Esa1 function as histone crotonyltransferases
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ers of a subset of the crotonate-induced genes, suggesting they
play a direct role in regulating crotonylation-dependent tran-
scription. This was further corroborated by the fact that acety-
lation levels remained unaffected at these promoters. On the
other hand, the subset of gene promoters at which we did not
observe ADA/SAGA (Gcn5 and Spt7) and Piccolo NuA4 (Epl1)
accumulation are likely regulated through secondary transcrip-
tional changes induced by crotonate treatment. These changes
could be Gcn5 and Esa1-dependent and -independent.
Because Gcn5 and Esa1 generate multiple acyl modifications
on chromatin, specificity in the transcriptional response has to
come from other factors that act downstream of Gcn5 and Esa1.
Downstream of acyl writer proteins, acyl-specific reader pro-
teins such as YEATS domain proteins or double PHD finger
proteins have a higher affinity for crotonylation compared with
acetylation (42, 43), and can therefore compete for acylation
binding (13, 44 –46). YEATS domain proteins, such as the
reader protein Taf14, could induce the distinct transcriptional
changes evoked by changes in histone crotonylation through
Gcn5 or Esa1. Further studies are required to better understand
the mode-of-action of these proteins in “reading” distinct acy-
lation modifications during transcription regulation and other
yet-to-be identified acylation-dependent processes.
Experimental procedures
Yeast strains, cell lines, plasmids and antibodies
Yeast strains and plasmids used in this study are listed in
Tables 1 and 2. pRS315-GCN5 plasmid was obtained from Dr.
Paul van Heusden (Leiden University, The Netherlands) (47).
Histone H3 and H4 mutant collection was purchased from
Dharmacon. Human HeLa cells were STR genotypes and cul-
tured in 5% CO2 at 37 °C in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal calf serum and antibiot-
ics. No-FRB and Esa1-N-FRB strains were constructed based
on conventional PCR-based transformation protocols. Detailed
construction information is available upon request. For N-ter-
minal tagging of the Esa1 protein, 500 bp upstream and 500 bp
Figure 5. Crotonate-induced transcription depends on Gcn5 and Esa1. A–H, RT-qPCR analysis of crotonate-treated WT, gcn5, and Esa1-N-FRB cells. The
2-Ct relative quantitative method was used to analyze the level of mRNA expression compared with untreated WT cells. Expression was normalized to ACT1.
Data are represented as the mean fold-change in relative expression due to crotonate addition from at least three independent experiments mean  S.E.
Figure 6. Crotonate-dependent recruitment of Gcn5, Spt7, and Epl1 to gene promoters. ChIP-qPCR analysis of (A) Gcn5-Myc, (B) Spt7-Myc, and (C)
Epl1-Myc at gene promoters before and after crotonate treatment. Data represent the mean fold-enrichment over an IgG control ChIP from three independent
experiments mean  S.E.
Gcn5 and Esa1 function as histone crotonyltransferases
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downstream sequences from the start codon were inserted in
pFA6a-KanMX6 plasmid (48) after the KanMX6 cassette using
Gibson assembly cloning (New England Biolabs, E2611). The
FRB tag (32) was then inserted after the start codon using Gib-
son assembly cloning. Cells were transformed with PCR prod-
uct obtained by PCR on the resulting plasmid using forward
primer (40 bp before Esa1 start codon  GAATTCGAGCTC-
GTTTAAAC) and reverse primer (20 bp reverse complement
sequence before position 500 bp) and selected for G418 resis-
tance. The region corresponding to the N-terminal region of
the protein was sequence verified. The yeast strain used for
transformation was previously mutated (tor1-1 mutation and
FPR1 deletion) to make the cells resistant to rapamycin, while
Rpl13a was tagged with FKBP12, as described (32). The pST44-
yAda3t2HISx3-yAda2 	 3-yGcn5 	 5 polycistronic vector
containing yeast GCN5, ADA2, and ADA3 was provided by
Dr. Sean Taverna (Johns Hopkins University School of Medi-
cine) (25). The pREST B-GCN5 plasmid was provided by Dr.
Min-Hao Kuo (Michigan State University) (49). The pST44-
yEpl1A3 	 3-Yng2A1 	 3-HISyEsa1 polycistronic vector con-
taining yeast ESA1, YNG2, and EPL1 was provided by Dr. Song
Tan (The Pennsylvania State University) (28). The catalytically-
dead Gcn5-E173H mutant was generated by site-directed
mutagenesis of pST44-yAda3t2HISx3-yAda2 	 3-yGcn5 	 5,
whereas the catalytically-dead Esa1-E338Q mutant was gener-
ated by site-directed mutagenesis of pST44-yEpl1A3 	
3-Yng2A1 	 3-HISyEsa1. Antibodies used were anti-pan-
acetylation (PTM-105; PTM-Biolabs), anti-pan-crotonylation
(PTM-501; PTM Biolabs), anti-H3K9cr (PTM-516; PTM Bio-
labs), anti-H3K14cr (GC-545; PTM Biolabs), anti-H3K18cr
(PTM-517; PTM Biolabs), anti-Pgk1 (number 459250; Invitro-
gen), anti-H3 (ab1791; Abcam), anti-H4ac (06-946, penta;
Upstate), and anti-H4 (ab7311; Abcam).
Recombinant protein purification
BL21-CodonPlus (DE3)-RIL E. coli cells (Agilent) were trans-
formed with pST44-yAda3t2HIS 	 3-yAda2 	 3-yGcn5 	 5 or
pST44-yEpl1A3 	 3-Yng2A1 	 3-HISyEsa1 plasmids and
grown overnight in the presence of 1 mM isopropyl 1-thio--D-
galactopyranoside. Cell pellets were lysed (50 mM Tris, pH 7.5,
500 mM NaCl, 10% glycerol, BugBuster 1x (Merck), 1 mM
MgCl2, 10 mM -mercaptoethanol, 15 kilounits of lysozyme,
250 units of benzonase, 1 tablet protease inhibitors (Sigma, 1
tablet cOmpleteTM, Mini, EDTA-free Protease Inhibitor Mix-
ture Protease Inhibitor Mixture)), and sonicated. Salt concen-
tration in the supernatant was lowered to 100 mM NaCl by
adding 50 mM Tris, pH 7.5, 10% glycerol, and 10 mM -mercap-
toethanol. The lysate was loaded on an ÄKTA Pure Chroma-
tography System on which a 1-ml HiTrapQ HP column was
installed (GE Healthcare). The column was washed with 5 col-
umn volumes of wash buffer (20 mM Tris, pH 8, 100 mM NaCl,
10% glycerol, 10 mM -mercaptoethanol). Elution was per-
formed by raising the NaCl concentration to 500 mM in the
wash buffer and using a 20-column volume linear gradient
while collecting 2-ml fractions. Gcn5-Ada2-Ada3 or Esa1-
Yng2-Epl1 complexes were purified on nickel beads using C
terminally His-tagged Ada3 or Esa1. Nickel bead suspension
(Qiagen) was added to the tubes and incubated for 1 h at 4 °C.
Beads were washed 3 times and proteins were eluted 3 times in
200 l elution buffer (50 mM Tris, pH 7.5, 500 mM NaCl, 10%
glycerol, 300 mM imidazole). Eluates were transferred to 100-
kDa Vivaspin 500 filter cups (Sartorius) to lower the imidazole
concentration and concentrate the purified complexes. The
residual was snap frozen in liquid nitrogen and stored at 
80 °C.
Nucleosome reconstitution
Purified histones and mononucleosomes were isolated as
described (24, 50).
In vitro acylation assays
Histone acylation assays were performed with recombi-
nant WT Gcn5-Ada2-Ada3 complex, catalytically-dead
Gcn5(E173H)-Ada2-Ada3 complex, WT Esa1-Yng2-Epl1, and
catalytically-dead Esa1(E338Q)-Yng2-Epl1 using 0.5 M his-
tone octamers and 30 M acetyl-CoA, 300 M butyryl-CoA, 300
M crotonyl-CoA, or 300 M succinyl-CoA in reaction buffer
(50 mM Tris-Cl, pH 7.5; 100 mM NaCl; 1 mM EDTA, 1 mM DTT)
with a final volume of 20 l. Mononucleosomes were used at a
concentration of 0.5 M. Reactions were performed for 1 h at
30 °C. Reactions were inhibited by adding sample buffer and




yHA-829 wildtype MATa can1-STE2pr-Sphis5 lyp1 his31 leu20 ura30 met150 ho (Barcoder001)KanMX NKI 4560 (53)
yHA-1028 gcn5 MATa can1-STE2pr-Sphis5 lyp1 his31 leu20 ura30 met150 ho(Barcoder)KanMX gcn5::NatMX 54
Histone H3 and H4 mutant
collection
MATa his3200 leu20 lys20 trp163 ura30 met150 can1::MFA1pr-HIS3 hht1-hhf1::NatMX4
hht2-hhf2::[HHTS-HHFS]*-URA3
55
acs1NatMX collection MATa can1-STE2pr-Sphis5 lyp1 his31 leu20 ura30 met150 ho(Barcoder)KanMX acs1::NatMX 54
Acs2 DaMP NatMX DaMP
collection
MAT can1-STE2pr-Sphis5 lyp1-STE3pr-LEU2 his31 leu20 ura30 met150 56
QY3530a No-FRB MATa ho hml::ADE1 hmr::ADE1 ade1–100 leu2–3,112 lys5 trp1::hisG ura3–52 ade3::GAL10::HO tor1–1::URAMX
fpr1::HphMX Rpl13A-2*FKBP12::TRP
This study
QY3562 RPO21-FRB Isogenic to QY3530 except RPO21-FRB::KanMX This study
QY3572a ESA1-N-FRB Isogenic to QY3530 except ESA1-FRB::KanMX This study
QY237 EPL1–13MYC MATa his31 leu20 ura30 met150 EPL1–13MYC::HIS3 57
QY3686 SPT7-MYC MATa ho hml::ADE1 hmr::ADE1 ade1–100 leu2–3,112 lys5 trp1::hisG ura3–52 ade3::GAL10::HO SPT7–13MYC::TRP This study
yHA-1078 GCN5-MYC Isogenic to yHA-829 except GCN5-MYC::HpH This study




pHA-434 pST44-yAda3t2HISx3-yAda2 	 3-yGCN5 	 5 25
pHA-485 pST44-yAda3t2HISx3-yAda2 	 3-yGCN5(E173H)x5 This study
pHA-431 pRSET–6xHis-T7-GCN5 49
pHA-436 pST44-yEpl1A3 	 3-Yng2A1 	 3-HISyEsa1 28
pHA-700 pST44-yEpl1A3 	 3-Yng2A1 	 3-HISyEsa1(E338Q) This study
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on SDS-PAGE, the gel was stained with Coomassie, and bands
corresponding to H3 and H4 were excised from the gel for
analysis.
Mass spectrometry
Gel slices containing histone H3 or H4 protein were sub-
jected to reduction with DTT and alkylation with iodoacet-
amide using Proteineer DP digestion robot (Bruker). Next,
lysines were modified with acetic acid anhydride to block
excessive tryptic cleavage of the arginine- and lysine-rich
histone proteins. We used deuterated acetic acid anhydride
to discriminate between acetylation by the Gcn5-Ada2-Ada3
and Esa1-Yng2-Epl1 complexes and the blocking agent.
Slices were incubated for 1 h at room temperature in 20%
(v/v) acetic anhydride-d6 (Sigma-Aldrich, 175641), 60% (v/v)
methanol, and 10 mM NH4HCO3, pH 8.4. Next, they were
washed three times with acetonitrile and 10 mM NH4HCO3,
pH 8.4, prior to protein digestion with trypsin. Peptides were
lyophilized, dissolved in 95/3/0.1 (v/v/v), water/acetonitrile/
formic acid, and subsequently analyzed by on-line C18 nano-
HPLC MS/MS with a system consisting of an Easy nLC 1200
gradient HPLC system (Thermo, Bremen, Germany), and a
LUMOS mass spectrometer (Thermo). Fractions were
injected onto a homemade precolumn (100 m 	 15 mm;
Reprosil-Pur C18-AQ 3 m, Dr. Maisch, Ammerbuch, Ger-
many) and eluted via a homemade analytical nano-HPLC
column (30 cm 	 50 m; Reprosil-Pur C18-AQ 3 m). The
gradient was run from 10 to 40% in solvent B (20/80/0.1,
water/acetonitrile/formic acid (FA) (v/v)) for 30 min. The
nano-HPLC column was drawn to a tip of 5 m and acted
as the electrospray needle of the MS source. The LUMOS
mass spectrometer was operated in data-dependent MS/MS
mode for a cycle time of 3 s, with a HCD collision energy at 32
V, and recording of the MS2 spectrum in the Orbitrap. In the
master scan (MS1) the resolution was 120,000, the scan
range was 400 –1500, at an AGC target of 400,000 at a max-
imum fill time of 50 ms. Dynamic exclusion after n  1 with




oHA-1984 GCN5 E173H F GACCTTTCGATAAGAGAGAGTTCGCACATATTGTTTTCTGTGCCATCAG
oHA-1985 GCN5 E173H R TGCGAACTCTCTCTTATCGAAAGGTCGATATGTTATGCCACCTACG
oHA-2278 ESA1 E338Q F CAAAGTTGGTTCTCCCCAGAAACCTTTGTCTG
oHA-2279 ESA1 E338Q R CAGACAAAGGTTTCTGGGGAGAACCAACTTTG
oHA-3211 FIG1 RT-qPCR F GATCCGGTTACATGGGTGTT
oHA-3212 FIG1 RT-qPCR R GACAACGCTTGATTGGGTTT
oHA-3213 AGA1 RT-qPCR F TCAAGCTGGCACTACGACAT
oHA-3214 AGA1 RT-qPCR R AAGGACTTATTTCGGCAGCA
oHA-3215 ALG12 RT-qPCR F GAATGGTGTCTACCTGAG
oHA-3216 ALG12 RT-qPCR R AAGTAATGCGTGAAATAAG
oHA-3217 BTN2 RT-qPCR F ACTTTGGATTTCTCTGTGTCTGG
oHA-3218 BTN2 RT-qPCR R CTGCTTAGGGACTCGTTGTATC
oHA-3219 RGT2 RT-qPCR F GCCTACGACAGAGGGAAGAA
oHA-3220 RGT2 RT-qPCR R CTGTGTATGCATTGCGGTGT
oHA-3221 ADE17 RT-qPCR F TATCACACATGCCCCAGAAA
oHA-3222 ADE17 RT-qPCR R CCCTAGCAAGGATACCACCA
oHA-3223 SHM2 RT-qPCR F AAAGGGTGTTGATGGTGCTC
oHA-3224 SHM2 RT-qPCR R CACCTGGAACCAAAGCAGAT
oHA-3225 HTX2 RT-qPCR F TCGTGCTATGGCTATTGCTG
oHA-3226 HTX2 RT-qPCR R ACCAAACAGCCCATGAAGAC
oHA-3227 ACT1 RT-qPCR F ACGTTCCAGCCTTCTACGTTTCCA
oHA-3228 ACT1 RT-qPCR R TCGAAGTCCAAGGCGACGTAACAT
oHA-3229 ATO2 ChIP-qPCR F GGAACGGCTCCATCCTAAAT
oHA-3230 ATO2 ChIP-qPCR R CCAGAAATGAGGAGACTGTTGA
oHA-3231 YGP1 ChIP-qPCR F AGAGGCTCAGGAGCTGAAA
oHA-3232 YGP1 ChIP-qPCR R TGTTGAACTGTAGCATCGAGAAG
oHA-3233 RGT2 ChIP-qPCR F CTCTGCTGTGGTTCCTCTTTATC
oHA-3234 RGT2 ChIP-qPCR R TGGAATGAGTTCCTTGCGATAC
oHA-3235 ROX1 ChIP-qPCR F CTTGGCGATTGCTGACAAAG
oHA-3236 ROX1 ChIP-qPCR R GGCAAGACAATACGAGGAAGA
oHA-3237 HXT2 ChIP-qPCR F GACTTCTTCTCCTCCCACAAA
oHA-3238 HXT2 ChIP-qPCR R TCTCCGGATTCATAAGGATTAGC
oHA-3239 PHO4 ChIP-qPCR F GCCGTAGGTACGTTCATTTCTA
oHA-3240 PHO4 ChIP-qPCR R GCACTTGCAGCATAGGAAATAC
oHA-3241 HXT1 ChIP-qPCR F GAAGTGACCCAGTGCTCTTT
oHA-3242 HXT1 ChIP-qPCR R CCTGCAGCATTTCTTCCTAGT
oHA-3243 SHM2 ChIP-qPCR F CTGCCCACACTGCTTATAGT
oHA-3244 SHM2 ChIP-qPCR R GACTCGACCGACTCTGTTTC
oHA-3245 ACT1 ChIP-qPCR F GATGAAGCTCAATCCAAGAGAGG
oHA-3246 ACT1 ChIP-qPCR R AGTTGGTGGAGAAAGAGTAACCACG
oHA-3247 ADE17 ChIP-qPCR F ACTGCCACCGGTAAGAAATC
oHA-3248 ADE17 ChIP-qPCR R CTATACCTCCATAACGACAGAGTATTT
oHA-3249 AGA1 ChIP-qPCR F TCCCTACATGCTTCGGAATTT
oHA-3250 AGA1 ChIP-qPCR R GGTGGCTGCTGAGATCTTTA
oHA-3251 FIG1 ChIP-qPCR F TCCAAGAATGCCGGTGATATG
oHA-3252 FIG1 ChIP-qPCR R AGGCAATGCAGGGTGATTT
oHA-3253 BTN2 ChIP-qPCR F AGCATGCTGTAGTGTATGTACTG
oHA-3254 BTN2 ChIP-qPCR R ACAGACGGTGCGAAAGAAA
oHA-3255 ALG12 ChIP-qPCR F CCACTTGCTTGTTTACCCTTTC
oHA-3256 ALG12 ChIP-qPCR R ACTACCCTGCCTCGTAACA
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For MS2 precursors were isolated with the quadrupole with
an isolation width of 1.2 Da. First mass was set to 110 Da. The
MS2 scan resolution was 30,000 with an AGC target of
50,000 at a maximum fill time of 60 ms.
In a post-analysis process, raw data were first converted to
peak lists using Proteome Discoverer version 2.2.0.388
(Thermo Electron), and then submitted to the Uniprot data-
base (452772 entries) using Mascot version 2.2.04 (Matrix Sci-
ence) for protein and peptide identification. Mascot searches
were with 10 ppm and 0.02 Da deviation for precursor and
fragment mass, respectively, and trypsin as enzyme with up to
two missed cleavages allowed. Methionine oxidation and
d6-acetylation, acetylation, and crotonylation of lysines were
set as variable modification. Carbamidomethyl on cysteine was
set as a fixed modification. The false discovery rate was set to 1%
and the Mascot ion threshold score to 35. All reported acety-
lated and crotonylated spectra were also inspected manually.
Peptides are listed in Table S2. Mass spectrometry data have
been uploaded to the PRIDE repository (accession number
PXD015488).
RNA-Seq
Three independent yeast colonies were used for inoculation.
Overnight cultures were diluted in fresh medium with or with-
out 10 mM sodium crotonate (Sigma-Aldrich) in the presence of
0.8 M sorbitol (Sigma-Aldrich). After 3.5 h cells were in early
log-phase (1 	 107 cells/ml) and harvested by centrifugation.
Total RNA was isolated using the RNeasyMini kit (Qiagen) and
treated with the RNase-free DNase Set (Qiagen) to remove any
contaminating genomic DNA. Library preparations were per-
formed with the TruSeq Stranded mRNA Library kit (Illumina).
Three independent biological replicates for each condition
were subjected to RNA-seq analysis using an Illumina NextSeq500
with a 75-bp single read flowcell. The raw source data files are
available via ArrayExpress, accession number E-MTAB-7471.
Reads were aligned to the UCSC SacCer3 reference genome (April
2011) using Tophat20 with the following parameters “-G
SacCer3_SGD.gtf-I 1000-i 20-p 6-o,” and counted with HTSeq
with the following parameters “htseq-count-f bam-stranded 
yes.” Differential expression was analyzed in R by DESeq2 (51)
using the default parameters, including the Benjamini-Hochberg
procedure for adjusting p values for multiple testing by converting
them to padj. GO term analysis was performed with the GO Term
Finder (version 0.86) of the Saccharomyces Genome Database
(www.yeastgenome.org).3
RT-qPCR
Total RNA was isolated using the RNeasy Mini kit (Qiagen)
and treated with the RNase-free DNase Set (Qiagen) to remove
any contaminating genomic DNA. cDNA was prepared from
total RNA using the GoScriptTM Reverse Transcription System
according to the manufacturer’s protocol (Promega). qPCR was
performed using GoTaq qPCR Master Mix (Promega). Expres-
sion levels were quantified using the 2-Ct method with
ACT1 as a reference. Specificity of primers was confirmed by
melting curve analysis and tested for linear amplification. All
primers used in qPCR are listed in Table 3.
Western blot analysis
Whole cell extracts were prepared from 2.5 	 107 cells.
Cell pellets were incubated for 10 min in 1.85 N NaOH and 7.4%
-mercaptoethanol, followed by precipitation with trichloro-
acetic acid (TCA). Samples were dissolved and boiled in SDS-
PAGE sample. Proteins were resolved in 12% polyacrylamide
gels and transferred onto polyvinylidene difluoride mem-
branes. Membranes were blocked with blocking buffer (Rock-
land) in PBS followed by overnight incubation with primary
antibody in blocking buffer at 4 °C. Membranes were washed
with 0.1% Tween 20 in PBS. Secondary antibody incubations
were performed for 60 min in blocking buffer at room temper-
ature using LI-COR Odyssey IRDye 800CW (1:10,000).
Membranes were subsequently scanned on a LI-COR Odyssey
IR Imager (Biosciences).
Spot dilution assays
Serial dilutions (10-fold) of mid-log phase cells were spotted
on YPD plates and grown for 2–3 days at 30 °C.
ChIP-qPCR
ChIP was performed as described previously (52). Input and
immunoprecipitated DNA was analyzed by qPCR using prim-
ers listed in Table 3.
Statistical analysis
Statistical analysis of RT-qPCR and ChIP-qPCR experiments
was performed using two-way analysis of variance with correc-
tion for multiple comparisons using the Šídák method in
Prism8 software. Significance is indicated as: ***, p  0.001; **,
p  0.01; *, p  0.05; ns, not significant. All error bars represent
the mean  S.E.
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